Oncological applications of somatostatin analogues, Cancer Res, vol.48, pp.6977-6895, 1988. ,
Expression of Opioid Peptides in Tumors, New England Journal of Medicine, vol.317, issue.23, pp.1439-1443, 1987. ,
DOI : 10.1056/NEJM198712033172304
Opioid receptors and endogenous opioids in diverse human and animal cancers, J. Nati Cancer. Inst, vol.79, pp.1059-1065, 1987. ,
Molecular biology of somatostatin receptors, Endocr. Rev, vol.16, pp.427-442, 1995. ,
DOI : 10.1210/er.16.4.427
Molecular biologyof opioidreceptors, TrendsNeurosci, vol.16, pp.506-510, 1993. ,
Opiate Antagonists Can Inhibit Mammary Tumor Growth in Rats, Experimental Biology and Medicine, vol.161, issue.1, pp.18-20, 1979. ,
DOI : 10.3181/00379727-161-40479
The antimetastatic activity of enkephalin-like peptides, Cancer Letters, vol.35, issue.2, pp.133-138, 1987. ,
DOI : 10.1016/0304-3835(87)90036-X
The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors, Endocrine Reviews, vol.12, issue.4, pp.450-482, 1991. ,
DOI : 10.1210/edrv-12-4-450
Response of human lung tumor xenografts to treatment with a somatostatin analogue (Somatu line), Cancer Res, vol.50, pp.4360-4365, 1990. ,
Growth of human beast cancer cells inhibited by the somatostatin analog BIM-230'4C (Somatuline), Endocrinology, vol.128, pp.323-329, 1991. ,
Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells ,
Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients, Breast Cancer Research and Treatment, vol.11, issue.3, pp.175-184, 1990. ,
DOI : 10.1038/bjc.1957.43
Immunoreactive opioid peptides in human breast cancer, Am. J. Pathol, vol.134, pp.473-479, 1989. ,
Expression and localization of somatostatin receptor SSTRI, SSTR2, and SSTR3 messenger RNA in primary human tumors using in situ hybridization, Cancer Res, vol.54, pp.3455-3459, 1994. ,
In vitro detection of somatostatin receptors in human tumors, Metabolism, p.41, 1992. ,
DOI : 10.1159/000201082
Evaluation of Receptors for Somatostatin in Various Tumors Using Different Analogs*, The Journal of Clinical Endocrinology & Metabolism, vol.70, issue.3, pp.661-669, 1990. ,
DOI : 10.1210/jcem-70-3-661
Prognostic value of receptors for insulin-like growth factor I, somatostatin, and epidermal growth factor in human breast cancer, Cancer Res, vol.49, pp.7002-7009, 1989. ,
Molecular heterogeneity of somatostatin analogueBIM-230'4C receptors in human breast carcinoma cells using the chemical cross-linking assay, Cancer Res, vol.52, pp.843-850, 1992. ,
Antiproliferative effects of the somatostatin analogue octreotide (SMS 201â? " 995)on ZR-75-l human breast cancer cells in vivo and in vitro, Cancer Res, vol.52, pp.4973-4978, 1992. ,
The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors, European Journal of Pharmacology, vol.296, issue.2, 1995. ,
DOI : 10.1016/0014-2999(95)00703-2
Binding of opioids to human MCF-7 breast cancer cells and their effects on growth, Cancer Res, vol.50, pp.2234-2238, 1990. ,
LIGAND: A versatile computerized approach for characterization of ligand-binding systems, Analytical Biochemistry, vol.107, issue.1, pp.220-239, 1980. ,
DOI : 10.1016/0003-2697(80)90515-1
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, Journal of Immunological Methods, vol.65, issue.1-2, pp.55-63, 1973. ,
DOI : 10.1016/0022-1759(83)90303-4
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Analytical Biochemistry, vol.162, issue.1, pp.156-159, 1987. ,
DOI : 10.1016/0003-2697(87)90021-2
Somatostatin receptor subtype gene expression in human and rodent tumors, Life Sciences, vol.53, issue.1, pp.85-90, 1993. ,
DOI : 10.1016/0024-3205(93)90614-9
Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: Relationship to egf receptors, International Journal of Cancer, vol.183, issue.3, p.420, 1990. ,
DOI : 10.1016/S0344-0338(88)80154-7
Somatostatin receptor-positive primary breast tumors: Genetic, patient and tumor characteristics, International Journal of Cancer, vol.4, issue.3, pp.357-362, 1993. ,
DOI : 10.1093/ajcp/78.6.806
Human somatostatin receptor hSSTR2 may mediate the antiproliferative effect of octreotide, Gastroenterology, vol.104, pp.8-14, 1993. ,
Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding site, Molecular and Cellular Endocrinology, vol.99, issue.2, pp.259-268, 1994. ,
DOI : 10.1016/0303-7207(94)90016-7
Effect of epidermal growth factor on the proliferation of human epithelial cancer cell lines: correlation with the level of occupied EGF receptors, Anticancer Res, vol.11, pp.737-744, 1991. ,
Opiate antagonistic properties of an octapeptide somatostatin analog., Proc. NatI. Acad. Sci ,
DOI : 10.1073/pnas.79.15.4815
URL : http://www.pnas.org/content/79/15/4815.full.pdf
??-Opiate binding and morphine antagonism by octapeptide analogs of somatostatin, Peptides, vol.8, issue.5, pp.869-875, 1987. ,
DOI : 10.1016/0196-9781(87)90074-X